Van Cleef Asset Management,Inc Amgen Inc Transaction History

Van Cleef Asset Management,Inc

$876 Million
Q3 2024

A detailed history of Van Cleef Asset Management,Inc transactions in Amgen Inc stock. As of the latest transaction made, Van Cleef Asset Management,Inc holds 2,012 shares of AMGN stock, worth $550,100. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,012

Previous 2,027 0.74%

Holding current value

$550,100

Previous $633,000 2.37%

% of portfolio

0.07%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$309.38 - $337.38 $4,640 - $5,060	-15 Reduced 0.74%	2,012 $648,000
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $88,727 - $107,104	330 Added 19.45%	2,027 $576,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $31,711 - $37,498	-148 Reduced 8.02%	1,697 $376,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $50,386 - $64,022	-220 Reduced 10.65%	1,845 $484,000
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $381,825 - $424,904	-1,655 Reduced 44.49%	2,065 $502,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $54,817 - $60,642	-250 Reduced 6.3%	3,720 $900,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $74,580 - $85,350	-375 Reduced 8.63%	3,970 $893,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $73,230 - $85,338	330 Added 8.22%	4,345 $1.08 Million
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $22,352 - $27,429	-113 Reduced 2.74%	4,015 $947,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $191,521 - $229,482	-1,100 Reduced 21.04%	4,128 $799,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $50,010 - $58,623	300 Added 6.09%	5,228 $963,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $57,088 - $66,640	320 Added 6.94%	4,928 $959,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $118,585 - $133,689	-640 Reduced 12.2%	4,608 $955,000
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $14,114 - $15,853	85 Added 1.65%	5,248 $969,000
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $12,707 - $14,850	75 Added 1.47%	5,163 $880,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $33,758 - $37,718	-200 Reduced 3.78%	5,088 $885,000
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $884,629 - $1.01 Million	5,288	5,288 $986,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Cleef Asset Management,Inc, based on Form 13F filings with the SEC.

News

Stay updated on Van Cleef Asset Management,Inc with notifications on news.

Account

Van Cleef Asset Management,Inc Amgen Inc Transaction History